Advertisement
Screener

STAAR Surgical Co (STAA) Operating Lease, Expense

2.8 / 5 stars · 68/120 Roast Me

STAAR Surgical Co Operating Lease, Expense

STAAR Surgical Co (STAA) reported Operating Lease, Expense of $1.77 million for the 6-month period ending 2026-07-03, per its 10-Q filed 2026-08-12.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:OperatingLeaseExpense · last filed 2026-08-12

  • STAAR Surgical Co operating lease, expense for the quarter ending 2026-07-03 was $916.00K, a 9.31% increase year-over-year.
  • STAAR Surgical Co operating lease, expense for the quarter ending 2026-04-03 was $857.00K, a 16.63% decline year-over-year.
  • STAAR Surgical Co operating lease, expense for the quarter ending 2026-01-02 was $905.00K, a 6.99% decline year-over-year.
  • STAAR Surgical Co operating lease, expense for the quarter ending 2025-09-26 was $799.00K, a 19.29% decline year-over-year.
  • STAAR Surgical Co operating lease, expense for fiscal 2026 was $3.57M, a 0.22% increase from fiscal 2024.
  • STAAR Surgical Co operating lease, expense for fiscal 2024 was $3.56M, a 9.40% increase from fiscal 2023.
  • STAAR Surgical Co operating lease, expense for fiscal 2023 was $3.26M.
Period endOperating Lease, Expense 3 monthOperating Lease, Expense 6 monthOperating Lease, Expense 9 monthOperating Lease, Expense 12 month
2026-07-03$916.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12
$1.77M
10-Q · filed 2026-08-12
$2.68M
derived: sum of 3 quarters · filed 2026-08-12
$3.48M
derived: sum of 4 quarters · filed 2026-08-12
2026-04-03$857.00K
10-Q · filed 2026-05-13
$1.76M
derived: sum of 2 quarters · filed 2026-05-13
$2.56M
derived: sum of 3 quarters · filed 2026-05-13
$3.40M
derived: sum of 4 quarters · filed 2026-08-12
2026-01-02$905.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03
$1.70M
derived: sum of 2 quarters · filed 2026-03-03
$2.54M
derived: sum of 3 quarters · filed 2026-08-12
$3.57M
10-K · filed 2026-03-03
2025-09-26$799.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
$1.64M
derived: sum of 2 quarters · filed 2026-08-12
$2.67M
10-Q · filed 2025-11-05
$3.64M
derived: sum of 4 quarters · filed 2026-08-12
2025-06-27$838.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12
$1.87M
10-Q · filed 2026-08-12
$2.84M
derived: sum of 3 quarters · filed 2026-08-12
$3.83M
derived: sum of 4 quarters · filed 2026-08-12
2025-03-28$1.03M
10-Q · filed 2026-05-13
$2.00M
derived: sum of 2 quarters · filed 2026-05-13
$2.99M
derived: sum of 3 quarters · filed 2026-05-13
2024-12-27$973.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03
$1.96M
derived: sum of 2 quarters · filed 2026-03-03
$3.56M
10-K · filed 2026-03-03
2024-09-27$990.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
$2.59M
10-Q · filed 2025-11-05
2024-06-28$1.60M
10-Q · filed 2025-08-06
2023-12-29$3.26M
10-K · filed 2026-03-03

Similar stocks

Stock NameCountryMarket CapPE Ratio
National Vision Holdings, Inc. (EYE)United States$1.297B
RxSight, Inc. (RXST)United States$0.197B
Innovative Eyewear Inc (LUCY)United States$0.008B
Warby Parker Inc. (WRBY)United States$2.970B
Bausch & Lomb Corp (BLCO)Canada$6.008B-34.58
COOPER COMPANIES, INC. (COO)United States$10.533B24.09